Skip to content
Hamad Medical Corporation
-
Hamad Medical Corporation signs MoU with Boehringer Ingelheim to transform Qatar’s clinical research
Under the partnership, the two organizations will work together to enhance HMC’s Clinical Trials Unit (CTU), strengthen research expertise, and develop initiatives that support the continued growth of Qatar’s healthcare sector.